225 related articles for article (PubMed ID: 9391085)
1. Telomerase activity: a biomarker of cell proliferation, not malignant transformation.
Belair CD; Yeager TR; Lopez PM; Reznikoff CA
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13677-82. PubMed ID: 9391085
[TBL] [Abstract][Full Text] [Related]
2. Telomerase activity: a biomarker of cell proliferation, not malignant transformation.
Droller MJ
J Urol; 1998 Aug; 160(2):620-1. PubMed ID: 9679941
[No Abstract] [Full Text] [Related]
3. Implications of TERT promoter mutations and telomerase activity in urothelial carcinogenesis.
Günes C; Wezel F; Southgate J; Bolenz C
Nat Rev Urol; 2018 Jun; 15(6):386-393. PubMed ID: 29599449
[TBL] [Abstract][Full Text] [Related]
4. Telomerase activity in diagnosis of bladder cancer.
Erdem E; Dikmen G; Atsü N; Dogan P; Ozen H
Scand J Urol Nephrol; 2003; 37(3):205-9. PubMed ID: 12775275
[TBL] [Abstract][Full Text] [Related]
5. Telomerase activity in patients with transitional cell carcinoma: a preliminary study.
Rahat MA; Lahat N; Gazawi H; Resnick MB; Sova Y; Ben-Ari G; Cohen M; Stein A
Cancer; 1999 Feb; 85(4):919-24. PubMed ID: 10091771
[TBL] [Abstract][Full Text] [Related]
6. Overcoming cellular senescence in human cancer pathogenesis.
Yeager TR; DeVries S; Jarrard DF; Kao C; Nakada SY; Moon TD; Bruskewitz R; Stadler WM; Meisner LF; Gilchrist KW; Newton MA; Waldman FM; Reznikoff CA
Genes Dev; 1998 Jan; 12(2):163-74. PubMed ID: 9436977
[TBL] [Abstract][Full Text] [Related]
7. Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer.
Kinoshita H; Ogawa O; Kakehi Y; Mishina M; Mitsumori K; Itoh N; Yamada H; Terachi T; Yoshida O
J Natl Cancer Inst; 1997 May; 89(10):724-30. PubMed ID: 9168188
[TBL] [Abstract][Full Text] [Related]
8. Comparison of human telomerase reverse transcriptase messenger RNA and telomerase activity as urine markers for diagnosis of bladder carcinoma.
Bialkowska-Hobrzanska H; Bowles L; Bukala B; Joseph MG; Fletcher R; Razvi H
Mol Diagn; 2000 Dec; 5(4):267-77. PubMed ID: 11172490
[TBL] [Abstract][Full Text] [Related]
9. Activities of MAP-kinase pathways in normal uroepithelial cells and urothelial carcinoma cell lines.
Swiatkowski S; Seifert HH; Steinhoff C; Prior A; Thievessen I; Schliess F; Schulz WA
Exp Cell Res; 2003 Jan; 282(1):48-57. PubMed ID: 12490193
[TBL] [Abstract][Full Text] [Related]
10. Non-radioactive measurement of telomerase activity in human bladder cancer, bladder washings, and in urine.
Heine B; Hummel M; Müller M; Heicappell R; Miller K; Stein H
J Pathol; 1998 Jan; 184(1):71-6. PubMed ID: 9582530
[TBL] [Abstract][Full Text] [Related]
11. Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma.
Messing EM
Cancer Res; 1990 Apr; 50(8):2530-7. PubMed ID: 1690599
[TBL] [Abstract][Full Text] [Related]
12. Significant telomere reduction in human superficial transitional cell carcinoma.
Kamata S; Kageyama Y; Yonese J; Oshima H
Br J Urol; 1996 Nov; 78(5):704-8. PubMed ID: 8976764
[TBL] [Abstract][Full Text] [Related]
13. Telomerase activity: a potential marker of bladder transitional cell carcinoma in bladder washes.
Yang SC; Lee DH; Hong SJ; Chung BH; Kim IY
Yonsei Med J; 1997 Jun; 38(3):155-9. PubMed ID: 9259615
[TBL] [Abstract][Full Text] [Related]
14. Neoplastic progression by EJ/ras at different steps of transformation in vitro of human uroepithelial cells.
Pratt CI; Kao CH; Wu SQ; Gilchrist KW; Oyasu R; Reznikoff CA
Cancer Res; 1992 Feb; 52(3):688-95. PubMed ID: 1310069
[TBL] [Abstract][Full Text] [Related]
15. PinX1 suppresses bladder urothelial carcinoma cell proliferation via the inhibition of telomerase activity and p16/cyclin D1 pathway.
Liu JY; Qian D; He LR; Li YH; Liao YJ; Mai SJ; Tian XP; Liu YH; Zhang JX; Kung HF; Zeng YX; Zhou FJ; Xie D
Mol Cancer; 2013 Nov; 12(1):148. PubMed ID: 24268029
[TBL] [Abstract][Full Text] [Related]
16. Complexity, retinoid-responsive gene networks, and bladder carcinogenesis.
Hurst RE; Waliszewski P; Waliszewska M; Bonner RB; Benbrook DM; Dar A; Hemstreet GP
Adv Exp Med Biol; 1999; 462():449-67. PubMed ID: 10599447
[TBL] [Abstract][Full Text] [Related]
17. Telomerase: a potential marker of bladder transitional cell carcinoma in bladder washes.
Lee DH; Yang SC; Hong SJ; Chung BH; Kim IY
Clin Cancer Res; 1998 Mar; 4(3):535-8. PubMed ID: 9533519
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma.
Moussa M; Omran Z; Nosseir M; Lotfy A; Swellam T
APMIS; 2009 Jan; 117(1):45-52. PubMed ID: 19161536
[TBL] [Abstract][Full Text] [Related]
19. Prostate stem cell antigen is overexpressed in human transitional cell carcinoma.
Amara N; Palapattu GS; Schrage M; Gu Z; Thomas GV; Dorey F; Said J; Reiter RE
Cancer Res; 2001 Jun; 61(12):4660-5. PubMed ID: 11406532
[TBL] [Abstract][Full Text] [Related]
20. Telomerase activity in human urothelial tumors.
Kyo S; Kunimi K; Uchibayashi T; Namiki M; Inoue M
Am J Clin Pathol; 1997 May; 107(5):555-60. PubMed ID: 9128268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
